The total revenue of that top 10 is 60% European companies and 40% American.
Now if this TTP chapter is two-way and with that equaly so for European markets then if anything would it not favour Europe more. Though between the two collectives involved. This only shuts out generics made outside of those two markets more than currently.
As for doctors without borders, they operate outside this trade agreement location wise and would not that open up for cheaper supplies from the producers outside this trade agreement. I would of thought so.
Though would perhaps, once settle reduce production runs of generics in some area's that depended upon this `sudo` gr[a¦e]y market. Then that may raise production costs, though if mroe than one generic then it would become more a price war without the more fruitful markets to utilise. Though always new markets and myself not sure about medical drugs and Russia and how that works at all.
But really such agreements need to be public before signing as about trade for the people as a whole and not a niche area that impacts national security of the people.
So the whole aspect not public just does not sit well, nor bode well for trust or indeed any scrutinising and that which has and has leaked. Just hard to get the full picture as hard to scale.
The total revenue of that top 10 is 60% European companies and 40% American.
Now if this TTP chapter is two-way and with that equaly so for European markets then if anything would it not favour Europe more. Though between the two collectives involved. This only shuts out generics made outside of those two markets more than currently.
As for doctors without borders, they operate outside this trade agreement location wise and would not that open up for cheaper supplies from the producers outside this trade agreement. I would of thought so.
Though would perhaps, once settle reduce production runs of generics in some area's that depended upon this `sudo` gr[a¦e]y market. Then that may raise production costs, though if mroe than one generic then it would become more a price war without the more fruitful markets to utilise. Though always new markets and myself not sure about medical drugs and Russia and how that works at all.
But really such agreements need to be public before signing as about trade for the people as a whole and not a niche area that impacts national security of the people.
So the whole aspect not public just does not sit well, nor bode well for trust or indeed any scrutinising and that which has and has leaked. Just hard to get the full picture as hard to scale.